FERMT2 and Sepsis: Specific rAAV-shRNA treatment in the TA muscle two weeks prior to sepsis induction, attenuated the upregulation of Ilk1 and Fermt2 mRNA, but did not affect muscle wasting, weakness or downstream signaling pathways.